139 related articles for article (PubMed ID: 20501634)
1. The effects of azole-based heme oxygenase inhibitors on rat cytochromes P450 2E1 and 3A1/2 and human cytochromes P450 3A4 and 2D6.
Hum M; McLaughlin BE; Roman G; Vlahakis JZ; Szarek WA; Nakatsu K
J Pharmacol Exp Ther; 2010 Sep; 334(3):981-7. PubMed ID: 20501634
[TBL] [Abstract][Full Text] [Related]
2. Selectivity of imidazole-dioxolane compounds for in vitro inhibition of microsomal haem oxygenase isoforms.
Kinobe RT; Vlahakis JZ; Vreman HJ; Stevenson DK; Brien JF; Szarek WA; Nakatsu K
Br J Pharmacol; 2006 Feb; 147(3):307-15. PubMed ID: 16331285
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of heme oxygenase-1 partially reverses the arsenite-mediated decrease of CYP1A1, CYP1A2, CYP3A23, and CYP3A2 catalytic activity in isolated rat hepatocytes.
Anwar-Mohamed A; Klotz LO; El-Kadi AO
Drug Metab Dispos; 2012 Mar; 40(3):504-14. PubMed ID: 22159698
[TBL] [Abstract][Full Text] [Related]
4. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes.
Foroozesh M; Primrose G; Guo Z; Bell LC; Alworth WL; Guengerich FP
Chem Res Toxicol; 1997 Jan; 10(1):91-102. PubMed ID: 9074808
[TBL] [Abstract][Full Text] [Related]
5. In vitro metabolism of the calmodulin antagonist DY-9760e (3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate) by human liver microsomes: involvement of cytochromes p450 in atypical kinetics and potential drug interactions.
Tachibana S; Fujimaki Y; Yokoyama H; Okazaki O; Sudo K
Drug Metab Dispos; 2005 Nov; 33(11):1628-36. PubMed ID: 16049129
[TBL] [Abstract][Full Text] [Related]
6. Proteolytic degradation of heme-modified hepatic cytochromes P450: A role for phosphorylation, ubiquitination, and the 26S proteasome?
Korsmeyer KK; Davoll S; Figueiredo-Pereira ME; Correia MA
Arch Biochem Biophys; 1999 May; 365(1):31-44. PubMed ID: 10222036
[TBL] [Abstract][Full Text] [Related]
7. In vitro effects of tacrolimus on human cytochrome P450.
Lecointre K; Furlan V; Taburet AM
Fundam Clin Pharmacol; 2002 Dec; 16(6):455-60. PubMed ID: 12685503
[TBL] [Abstract][Full Text] [Related]
8. Human liver microsomes are efficient catalysts of 1,3-butadiene oxidation: evidence for major roles by cytochromes P450 2A6 and 2E1.
Duescher RJ; Elfarra AA
Arch Biochem Biophys; 1994 Jun; 311(2):342-9. PubMed ID: 8203896
[TBL] [Abstract][Full Text] [Related]
9. Human reductive halothane metabolism in vitro is catalyzed by cytochrome P450 2A6 and 3A4.
Spracklin DK; Thummel KE; Kharasch ED
Drug Metab Dispos; 1996 Sep; 24(9):976-83. PubMed ID: 8886607
[TBL] [Abstract][Full Text] [Related]
10. Selectivities of human cytochrome P450 inhibitors toward rat P450 isoforms: study with cDNA-expressed systems of the rat.
Kobayashi K; Urashima K; Shimada N; Chiba K
Drug Metab Dispos; 2003 Jul; 31(7):833-6. PubMed ID: 12814958
[TBL] [Abstract][Full Text] [Related]
11. Assessment of drug-drug interaction for silymarin.
Doehmer J; Tewes B; Klein KU; Gritzko K; Muschick H; Mengs U
Toxicol In Vitro; 2008 Apr; 22(3):610-7. PubMed ID: 18249085
[TBL] [Abstract][Full Text] [Related]
12. Gender differences in microsomal metabolic activation of hepatotoxic clivorine in rat.
Lin G; Cui YY; Liu XQ
Chem Res Toxicol; 2003 Jun; 16(6):768-74. PubMed ID: 12807360
[TBL] [Abstract][Full Text] [Related]
13. Relative contributions of the five major human cytochromes P450, 1A2, 2C9, 2C19, 2D6, and 3A4, to the hepatic metabolism of the proteasome inhibitor bortezomib.
Uttamsingh V; Lu C; Miwa G; Gan LS
Drug Metab Dispos; 2005 Nov; 33(11):1723-8. PubMed ID: 16103134
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the enzymatic activity of heme oxygenases by azole-based antifungal drugs.
Kinobe RT; Dercho RA; Vlahakis JZ; Brien JF; Szarek WA; Nakatsu K
J Pharmacol Exp Ther; 2006 Oct; 319(1):277-84. PubMed ID: 16807364
[TBL] [Abstract][Full Text] [Related]
15. Selective inhibition of heme oxygenase, without inhibition of nitric oxide synthase or soluble guanylyl cyclase, by metalloporphyrins at low concentrations.
Appleton SD; Chretien ML; McLaughlin BE; Vreman HJ; Stevenson DK; Brien JF; Nakatsu K; Maurice DH; Marks GS
Drug Metab Dispos; 1999 Oct; 27(10):1214-9. PubMed ID: 10497150
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of cytochrome P450 reactions by apo-cytochrome b5: evidence against transfer of heme from cytochrome P450 3A4 to apo-cytochrome b5 or heme oxygenase.
Yamazaki H; Shimada T; Martin MV; Guengerich FP
J Biol Chem; 2001 Aug; 276(33):30885-91. PubMed ID: 11413149
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of cytochrome P450 1A2-mediated metabolism and production of reactive oxygen species by heme oxygenase-1 in rat liver microsomes.
Reed JR; Cawley GF; Backes WL
Drug Metab Lett; 2011 Jan; 5(1):6-16. PubMed ID: 20942796
[TBL] [Abstract][Full Text] [Related]
18. High-throughput cytochrome P450 (CYP) inhibition screening via a cassette probe-dosing strategy. VI. Simultaneous evaluation of inhibition potential of drugs on human hepatic isozymes CYP2A6, 3A4, 2C9, 2D6 and 2E1.
Bu HZ; Magis L; Knuth K; Teitelbaum P
Rapid Commun Mass Spectrom; 2001; 15(10):741-8. PubMed ID: 11344532
[TBL] [Abstract][Full Text] [Related]
19. Evidence for cytochrome P450 2A6 and 3A4 as major catalysts for N'-nitrosonornicotine alpha-hydroxylation by human liver microsomes.
Patten CJ; Smith TJ; Friesen MJ; Tynes RE; Yang CS; Murphy SE
Carcinogenesis; 1997 Aug; 18(8):1623-30. PubMed ID: 9276639
[TBL] [Abstract][Full Text] [Related]
20. Polysaccharide peptides from Coriolus versicolor competitively inhibit model cytochrome P450 enzyme probe substrates metabolism in human liver microsomes.
Yeung JH; Or PM
Phytomedicine; 2012 Mar; 19(5):457-63. PubMed ID: 22305191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]